NDC product
Felodipine
NDC 0603-3583 · Par Health USA, LLC
Key facts
| Product NDC | 0603-3583 |
|---|---|
| Proprietary name | Felodipine |
| Nonproprietary name | Felodipine |
| Substances | FELODIPINE |
| Dosage form | TABLET, FILM COATED, EXTENDED RELEASE |
| Route | ORAL |
| Labeler | Par Health USA, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA200815 |
| Pharmacologic classes | Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS] |
| Marketing start | Dec 15, 2011 |
| Marketing end | Sep 30, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory